AAIC 2025 Abstract
Trajectories of CSF and plasma MTBR‐tau 243 and phosphorylated‐tau species across the Alzheimer's disease continuum
Study in peopleBiomarkers
Abstract
Background: To efficiently implement Alzheimer disease (AD) cerebrospinal fluid (CSF) and plasma tau biomarkers, it is key to understand how they change over the course of disease progression.
